Harnessing the therapeutic potential therapeutic efficacy of α-1 adrenergic blockers for Raynaud’s phenomenon and digital ischaemia secondary to central nervous system stimulants used for attention deficit hyperactivity disorder

  • Michael Hughes*
  • , Hafiz M. Umair
  • , Robert D Sandler
  • , Alessia Alunno
  • , Marco Matucci-Cerinic
  • *Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article number152114
JournalSeminars in arthritis and rheumatism
Volume57
Early online date21 Oct 2022
DOIs
Publication statusPublished - 1 Dec 2022

Cite this